Delafloxacin

Overview

Delafloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105637).

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Delafloxacin expires 2 Jun 2034 and exclusivity 19 Jun 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid

Canonical SMILES

C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O

InChIKey

DYDCPNMLZGFQTM-UHFFFAOYSA-N